Analyzing well-level data

An Introduction To High Content Screening: Imaging Technology, Assay Development, and Data Analysis in Biology and Drug Discovery

Volumn , Issue , 2015, Pages 131-144

  Haney, Steven A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85015372713     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118859391.ch9     Document Type: Chapter

References (17)

1. Birmingham, A., et al. Statistical methods for analysis of high-throughput RNA interference screens. Nature Methods, 2009, 6: 569-575.
2. Malo, N., et al. Statistical practice in high-throughput screening data analysis. Nature Biotechnology, 2006, 24(2): 167-175.
3. Zhang, X.D. Illustration of SSMD, z score, SSMD*, z* score, and t statistic for hit selection in RNAi high-throughput screens. Journal of Biomolecular Screening, 2011, 16: 775-785.
4. Høyer-Hansen, M. and Jäättelä, M. Autophagy-an emerging target for cancer therapy. Autophagy, 2008, 4(5): 574-580.
5. Haney, S.A. Rapid assessment and visualization of normality in high-content and other cell-level assays, and its impact on experimental results. Journal of Biomolecular Screening, 2014, 19(5): 672-684.
6. Bray, M.A. and Carpenter, A.E. Advanced assay development guidelines for image-based high content screening and analysis, in Assay Guidance Manual, 2012, National Institutes of Health, Bethesda, MD.
7. Chung, N., et al. Median absolute deviation to improve hit selection for genome-scale RNAi screens. Journal of Biomolecular Screening, 2008, 13: 149-158.
8. Brideau, C., et al. Improved statistical methods for hit selection in high-throughput screening. Journal of Biomolecular Screening, 2003, 8: 634-647.
9. Zhang, J.-H., Chung, T.D.Y., and Oldenberg, K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. Journal of Biomolecular Screening, 1999, 4: 67-73.
10. Ravkin, I. and Temov, V. Comparison of several classes of algorithms for cytoplasm to nucleus translocation. Tenth Annual Meeting of the Society for Biomolecular Screening, 2004.
11. Zhang, X.D. A pair on new statistical parameters for quality control in RNA interference high throughput screening assays. Genomics, 2007, 89: 552-561.
12. Bhinder, B. and Djaballah, H. A simple method for analyzing actives in random RNAi screens: introducing the "H Score" for hit nomination & gene prioritization. Combinatorial Chemistry and High Throughput Screening, 2012, 15: 686-704.
13. Zhang, X.D., et al. The use of strictly standardized mean difference for hit selection in primary RNA interference high throughput screening experiments. Journal of Biomolecular Screening, 2007, 12: 497-509.
14. Pan, J., et al. A kinome-wide siRNA screen identifies multiple roles for protein kinases in hypoxic stress adaptation, including roles for IRAK4 and GAK in protection against apoptosis in VHL-/- renal carcinoma cells, despite activation of the NF-kappaB pathway. Journal of Biomolecular Screening, 2013, 18(7): 782-796.
15. Whitehurst, A.W., et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature, 2007, 446: 815-819.
16. Shoichet, B.K. Interpreting steep dose-response curves in early inhibitor discovery. Journal of Medicinal Chemistry, 2006, 49: 7274-7277.
17. Fallahi-Sichani, M., et al. Metrics other than potency reveal systematic variation in responses to cancer drugs. Nature Chemical Biology, 2013, 9: 708-714.